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In Brief
Palmitoylation is a lipid-derived post-
translational modification (PTM). Foe
et al. report a comprehensive analysis of
palmitoylated proteins in Toxoplasma
gondii. They demonstrate that
palmitoylation is associated with diverse
aspects of T. gondii biology, including
motility and morphology, and reveal a
function for this PTM in regulating the
invasion-associated protein, AMA1.
Cell Host & Microbe
ResourceGlobal Analysis of Palmitoylated Proteins
in Toxoplasma gondii
Ian T. Foe,1,5 Matthew A. Child,1,5 Jaimeen D. Majmudar,2,5 Shruthi Krishnamurthy,3 Wouter A. van der Linden,1
Gary E. Ward,3 Brent R. Martin,2,* and Matthew Bogyo1,4,*
1Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
2Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA
3Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA
4Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
5Co-first author
*Correspondence: brentrm@umich.edu (B.R.M.), mbogyo@stanford.edu (M.B.)
http://dx.doi.org/10.1016/j.chom.2015.09.006SUMMARY
Post-translational modifications (PTMs) such as
palmitoylation are critical for the lytic cycle of the
protozoan parasite Toxoplasma gondii. While palmi-
toylation is involved in invasion, motility, and cell
morphology, the proteins that utilize this PTM remain
largely unknown. Using a chemical proteomic
approach, we report a comprehensive analysis of
palmitoylated proteins in T. gondii, identifying a total
of 282 proteins, including cytosolic, membrane-
associated, and transmembrane proteins. From this
large set of palmitoylated targets, we validate palmi-
toylation of proteins involved in motility (myosin light
chain 1, myosin A), cell morphology (PhIL1), and host
cell invasion (apical membrane antigen 1, AMA1).
Further studies reveal that blocking AMA1 palmitoy-
lation enhances the release of AMA1 and other
invasion-related proteins from apical secretory or-
ganelles, suggesting a previously unrecognized role
for AMA1. These findings suggest that palmitoylation
is ubiquitous throughout the T. gondii proteome and
reveal insights into the biology of this important hu-
man pathogen.
INTRODUCTION
The phylum Apicomplexa is composed of medically relevant
parasites, including Plasmodium falciparum and Toxoplasma
gondii, the causative agents of malaria and toxoplasmosis,
respectively. T. gondii is an obligate intracellular parasite that in-
fects approximately 30% of the world’s population (Robert-
Gangneux andDarde´, 2012). Themajority of infections are latent,
asymptomatic, and maintained indefinitely inside the host as
bradyzoite cysts. If an infected person becomes immunocom-
promised, cyst activation can cause acute toxoplasmosis, the
symptoms of which include blindness and neurological prob-
lems (Montoya and Liesenfeld, 2004; Robert-Gangneux and
Darde´, 2012). The T. gondii asexual lytic cycle comprises several
distinct processes, including host cell invasion, intracellularCell Hostreplication, and egress (Black and Boothroyd, 2000). Completion
of this cycle by tachyzoite-stage parasites is essential for para-
site survival within a host, and a better understanding of these
processes is prerequisite for the development of therapies to
combat infection.
Recent work has implicated the post-translational modifica-
tion (PTM) S-palmitoylation as being important for the tachyzoite
lytic cycle (Alonso et al., 2012). S-palmitoylation is the covalent
attachment of palmitate (Figure 1A), a saturated 16-carbon fatty
acid, via a thioester linkage to a cysteine residue (Linder and
Deschenes, 2007; Tom and Martin, 2013). Palmitoylation typi-
cally regulates protein membrane localization, but can also alter
protein stability, protein/protein interactions, and protein traf-
ficking (Linder and Deschenes, 2007; Salaun et al., 2010). Unlike
other lipid modifications, palmitoylation is reversible and dy-
namic (Martin et al., 2012). The addition of palmitate is catalyzed
by palmitoyl acyl transferases (PATs) (Linder and Deschenes,
2007). The T. gondii genome encodes 18 potential PATs, 16 of
which are expressed in tachyzoites (Fre´nal et al., 2013). There
are two primary families of palmitoyl thioesterases: palmitoyl
protein thioesterases, which remove palmitate from proteins
found in lysosomes, and acyl-protein thioesterases (APTs),
which target palmitoylated cytosolic proteins (Linder and De-
schenes, 2007). The T. gondii genome is predicted to encode
four APTs (Kemp et al., 2013), only one of which has confirmed
thioesterase activity (Child et al., 2013).
A growing body of work has implicated palmitoylation in mul-
tiple aspects of T. gondii biology. Treating tachyzoites with the
broadly reactive PAT inhibitor, 2-bromopalmitate (2-BP), inhibits
motility and host cell invasion and disrupts parasite morphology
(Alonso et al., 2012). Similarly, 2-BP treatment of blood-stage
P. falciparum inhibits invasion and alters parasite morphology
(Jones et al., 2012). Inhibition of a T. gondii APT (TgPPT1) results
in increased motility and invasion (Child et al., 2013). Despite the
importance of palmitoylation in the T. gondii asexual life cycle,
only five proteins have been definitively shown to be palmitoy-
lated, with mutational studies suggesting that eight others likely
have this PTM (Table 1). The full extent of protein palmitoylation
in T. gondii remains largely unknown and likely regulates many
aspects of parasite biology.
To understand the extent and function of palmitoylation in
T. gondii tachyzoite biology, we undertook a chemical proteomic
study to profile the full complement of palmitoylated proteins in& Microbe 18, 501–511, October 14, 2015 ª2015 Elsevier Inc. 501
Figure 1. Identification of Palmitoylated
Proteins in T. gondii Tachyzoites
(A) Chemical structure of palmitic acid and 17-
octadecynoic acid (17-ODYA).
(B) Left, diagram of approach to identify palmi-
toylated proteins. Right, ratio of average normal-
ized abundance scores of proteins isolated from
17-ODYA-treated parasites over average normal-
ized abundance in palmitic acid-treated parasites
(834 proteins), plotted against statistical signifi-
cance. Red dots are proteins with a fold change
(17-ODYA abundance/palmitic acid abundance)
ofR1.5 (p < 0.05) and that satisfied 5% FDR (501
proteins). Black dots are proteins with a fold
change of <1.5 and/or not statistically significant
(p > 0.05) and/or did not satisfy 5% FDR.
(C) Left, diagram of approach to identify 17-ODYA-
labeled proteins sensitive to hydroxylamine. Right,
ratio of average normalized abundance scores of
proteins isolated in 17-ODYA-treated samples
over average normalized abundance score of
proteins isolated from 17-ODYA treated samples
that were then treated with hydroxylamine, plotted
against statistical significance (501 proteins iden-
tified above). Red dots are proteins (282 proteins)
with a fold change (average 17-ODYA abundance/
average hydroxylamine abundance) of R1.0
(p < 0.05) and that satisfy 5% FDR. Black dots
are proteins with a fold change of <1 and/or not
statistically significant (p > 0.05) and/or did not
satisfy 5% FDR. See also Figure S1 and Table S1.T. gondii tachyzoites. These efforts identified proteins involved in
a variety of biological processes, including host cell invasion,
motility, morphology, signaling, stress response, and meta-
bolism. We biochemically confirm the palmitoylation of several
candidates from our proteomic analysis, including myosin light
chain 1 (MLC1) and myosin A (MyoA), components of the glideo-
some, the parasite’s motility complex (Herm-Go¨tz et al., 2002;
Meissner et al., 2002). We confirm that the morphology-associ-
ated photosensitized INA-labeled protein (PhIL1) (Barkhuff
et al., 2011; Gilk et al., 2006) is palmitoylated. Unexpectedly,
we found that apical membrane antigen 1 (AMA1), a protein
that functions during invasion (Hehl et al., 2000; Lamarque
et al., 2014; Mital et al., 2005), is palmitoylated. Mutation of the
identified palmitoylation site has no effect on invasion or protein
localization but markedly enhances microneme secretion and
affects the ability of parasites to complete the intracellular stages
of the lytic cycle. Combined, these findings reveal a valuable
dataset that will help to drive the discovery of specific functional
roles for palmitoylation in T. gondii tachyzoite biology.
RESULTS
Identification of Palmitoylated Proteins by Mass
Spectrometry
There have been a number of recent technological advances in
the use of chemical tools to study lipidated proteins (Hang
et al., 2007; Hannoush and Arenas-Ramirez, 2009; Heal et al.,502 Cell Host & Microbe 18, 501–511, October 14, 2015 ª2015 Elsev2008; Kostiuk et al., 2008; Martin and Cravatt, 2009). This in-
cludes the development of methods to apply the palmitic acid
analog 17-octadecynoic acid (17-ODYA) as a bioorthogonal
tag to identify palmitoylated proteins (Figure 1A) (Jones et al.,
2012; Martin and Cravatt, 2009). This palmitate mimetic contains
a terminal alkyne for ‘‘Click’’ reaction (copper-catalyzed cyclo-
addition) with azide-containing molecules such as biotin (for
affinity enrichment), or rhodamine (for in-gel visualization by
SDS-PAGE) (Martin and Cravatt, 2009). We have previously
used 17-ODYA to metabolically label T. gondii tachyzoites for
direct detection of specific palmitoylated proteins (Child et al.,
2013).We therefore applied this methodmore broadly to globally
profile palmitoylation in T. gondii.
To ensure complete analysis of all palmitoylated proteins, we
first determined the kinetics of labeling by 17-ODYA. We
observedmetabolic incorporation of 17-ODYA on proteins within
1 hr of incubation, with labeling saturated by 16 hr (Figure S1A).
We then treated parasites for 16 hr with a range of concentra-
tions of 17-ODYA to determine the optimal concentration to
use for our proteomic studies (Figure S1B). We chose a concen-
tration of 25 mM as it gave robust and consistent labeling, was
not toxic (Figure S1C), and was the concentration used for prior
human and P. falciparum palmitoylation studies (Jones et al.,
2012; Martin and Cravatt, 2009). For our proteomic workflow,
we metabolically labeled wild-type tachyzoites (RH strain) with
either 17-ODYA or palmitic acid for 16 hr, sonicated the para-
sites, and fractionated the resulting material into soluble andier Inc.
Table 1. Proteins with Prior Experimental Evidence of
Palmitoylation
Protein
Previous Evidence
of Palmitoylation Identified
Highly
NH2OH
Sensitive
NH2OH
Fold
Change
GAP45 Fre´nal et al., 2010
Child et al., 2013
Yes Yes 5.8
CDPK3 Lourido et al., 2012
McCoy et al., 2012
Garrison et al., 2012
Child et al., 2013
Yes No 1.4
ARO Beck et al., 2013
Mueller et al., 2013
Child et al., 2013
Yes Yes 2
HSP20 De Napoli et al., 2013 Yes Yes 3.4
HXGPRT Chaudhary et al., 2005 Yes Yes 3.2
MLC1 Fre´nal et al., 2010 Yes Yes 3.1
MLC2 Polonais et al., 2011 Yes Yes 5.6
IAP1 Fre´nal et al., 2014 Yes Yes 2.6
GAP70 Fre´nal et al., 2010 No – –
ISP1 Beck et al., 2010 No – –
ISP2 Beck et al., 2010 Yes No 1.1
ISP3 Beck et al., 2010 Yes Yes 1.8
ISP4 Fung et al., 2012 No – –
Hydroxylamine sensitivity (NH2OH) in the current study is shown, with fold
change after NH2OH treatment indicated.insoluble fractions. Previous studies employing this approach
have not observed significant 17-ODYA-dependent labeling of
soluble proteins (Martin and Cravatt, 2009), and we focused on
insoluble proteins for the remainder of the study. Accordingly,
this study does not include analysis of potentially soluble palmi-
toylated proteins. After chloroform/methanol precipitation, we
performed click conjugation of azido-biotin in the insoluble
membrane fraction and collected labeled proteins by streptavi-
din enrichment. Following trypsin digestion, we analyzed the
peptides by 1D reverse-phase nanoUPLC coupled to a quadru-
pole ion mobility time of flight mass spectrometer. We acquired
data using UDMSE methods (Distler et al., 2014) for label-free
data-independent acquisition (DIA). In this approach, data are
collected across the entire mass range, cycling between low
collision energy (precursors) and high collision energy (prod-
ucts), recording data for all precursor and product ions across
the entire elution gradient. After multi-dimensional alignment
by drift and elution times, precursor ions are matched to product
ions for database annotation using a 1% reverse-decoy false
discovery rate (FDR). Leveraging this DIA approach, we ex-
tracted ion intensities for each annotated peptide across each
1D experiment (four biological replicates, each the average of
three technical replicates) and normalized each dataset to pyru-
vate carboxylase, an endogenous biotinylated protein. This
approach yielded statistically robust, reproducible, label-free
quantitation with no gaps in data across experiments. In control
experiments using a standard HeLa digest (n = 4), the technical
error was approximately 17% (SD), ensuring statistically signifi-
cant quantitation of as little as 35% changes (2 SD) (Figure S1D).
Based on slightly more stringent thresholds, we identified andCell Hostquantified 501 T. gondii proteins statistically enriched (p <
0.05, >1.5-fold, 5% FDR) in 17-ODYA relative to the palmitic
acid control (Figure 1B, Table S1).
In addition to reversible S-palmitoylation, palmitate can be
irreversibly attached to the hydroxyl group of serine residues
(O-palmitoylation) (Zou et al., 2011) and to the amine group on
N-terminal cysteines (N-palmitoylation) (Linder and Deschenes,
2007). It can also be irreversibly incorporated into glycosylphos-
phatidylinositol (GPI) anchors such as on T. gondii, Subtilisin 1
(SUB1) (Binder et al., 2008). Consistent with this, SUB1 was
highly enriched in 17-ODYA samples (Table S1). Therefore,
to focus S-palmitoylated proteins, we performed a second
proteomic experiment where we treated samples with hydroxyl-
amine to hydrolyze any thioester linkages (Figure 1C). Following
label-free DIA analysis, we confirmed statistically significant
(p < 0.05) hydroxylamine hydrolysis for 282 proteins (Figure 1C,
Table S1), 210 of which were enriched >1.5-fold in the untreated
sample (highly hydroxylamine sensitive) and 72 of which were
enriched between 1- and 1.5-fold (sensitive). These 282 proteins
represent our final list of T. gondii palmitoylated proteins. (Fig-
ure 2A, Table S1). Importantly, this included 9 of the 13 estab-
lished palmitoylated proteins in our data (Table 1), suggesting
that the method was sufficiently robust to annotate the vast
majority of palmitoylated proteins. We predict this is an under-
representation of the number of T. gondii palmitoylated proteins,
as our analysis did not use extensive fractionation and focused
on a single life cycle stage. Nonetheless, the high statistical
confidence provides a broad profile of thioester-dependent 17-
ODYA labeling in T. gondii.
We next assessed how palmitoylation may be involved in
distinct aspects of the parasite asexual biology and found that
our dataset contained proteins involved in all aspects of the lytic
cycle (Figure 2B). In addition, we found that 37%of the highly hy-
droxylamine-sensitive proteins and 19% of sensitive proteins
were annotated as hypothetical (Figure 2C). Consistent with re-
ports that palmitoylation often occurs proximal to or within trans-
membrane (TM) domains (Charollais and Van Der Goot, 2009),
we found that TM domain-containing proteins were enriched in
the highly hydroxylamine-sensitive proteins in our dataset
(37%) compared to a T. gondii membrane proteome (30%)
(Che et al., 2011) and the predicted T. gondii proteome (20%)
(Figure 2C). In addition to TM domains, mammalian palmitoyla-
tion is enriched at cysteine residues close to the N terminus of
a protein when glycine is the second amino acid, which are
frequently myristoylated. Our dataset was not significantly
enriched for proteins with glycine in the second position, as
7%–8% of the proteins in our data had a glycine in this position,
compared to the T. gondiimembrane proteome (7%) (Che et al.,
2011) and the predicted proteome (6%) (Figure 2C). This lack of
enrichment may be an artifact of how we set our selection
criteria, as dually acylated proteins may be less sensitive to hy-
droxylamine treatment.
Recent proteomic studies have defined the P. falciparum pal-
mitome (Jones et al., 2012). Due to the relatedness of these two
organisms, we compared the P. falciparum palmitome and our
T. gondii dataset, helping us validate likely palmitoylation events
and identify modifications unique to either parasite. We initially
converted the entire P. falciparum palmitome dataset (Jones
et al., 2012) into putative T. gondii orthologs. This analysis& Microbe 18, 501–511, October 14, 2015 ª2015 Elsevier Inc. 503
Figure 2. Analysis of MS Data
(A) Pie chart depicting 282 proteins identified as putatively S-palmitoylated. Confidence intervals for hydroxylamine (NH2OH) sensitivity are indicated (highly
hydroxylamine sensitive >1.5 [blue], hydroxylamine sensitive 1.0–1.5 [red]). Total numbers of proteins in each interval are shown, as are the identities of the top 10
hits for both confidence levels.
(B) Proteins implicated in diverse functions are palmitoylated in T. gondii tachyzoites. Gene names and accession numbers are provided for a subset of proteins
from the MS dataset that highlight the diversity of palmitoylated proteins found. Black text is used to indicate palmitoylated proteins highly sensitive to
hydroxylamine, and red text indicates hydroxylamine-sensitive hits.
(legend continued on next page)
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Figure 3. Validation of a Subset of Palmitoy-
lated Proteins
In all cases, treatment with 5% hydroxylamine is
indicated by ±NH2OH.
(A) MLC1-FLAG IP showing that MLC1 is
palmitoylated. Top: rhodamine fluorescent scan
(R. scan) of SDS-PAGE showing palmitoylation of
MLC1. Bottom: corresponding western blot for
MLC1-FLAG IP, probed with anti-MLC1 antibody
(WB: MLC1).
(B) FLAG-MyoA IP showing that MyoA is
palmitoylated. Top: rhodamine fluorescent scan
(R. Scan) of SDS-PAGE showing palmitoylation of
MyoA. Co-precipitating species are tentatively
assigned identities based on electrophoretic
mobility and indicated on gel. Bottom: corre-
sponding western blot of FLAG-MyoA IP, probed
with anti-FLAG antibody (WB: FLAG).
(C) PhIL1-GFP IP showing palmitoylation of PhIL1.
Top: rhodamine fluorescent scan (R. scan) of SDS-
PAGE showing palmitoylation of PhIL1. Bottom:
corresponding western blot for PhIL1-GFP,
probed with anti-GFP antibody (WB: GFP).
(D) AMA1-FLAG IP showing palmitoylation of
AMA1. Top: rhodamine fluorescent scan (R. scan)
of SDS-PAGE showing palmitoylation of AMA1.
Bottom: corresponding western blot for AMA1 IP,
probed with anti-AMA1 antibody (WB: AMA1) See
also Figure S2.identified 391 T. gondii orthologs corresponding to 313 of the
494 P. falciparum proteins. Of these, 63 were shared between
our data and the entireP. falciparum palmitome (Figure 2D, Table
S2). We also observed limited overlap between our data and the
17-ODYA-generated P. falciparum palmitome (Figure 2E, Table
S2). The overlap between the datasets was unexpectedly small,
which could be due to substantial differences in the way the two
parasites use palmitoylation, overall poor homology between
palmitoylated proteins in these parasites, or that different life cy-
cle stages are being compared, i.e., intracellular P. falciparum
schizonts and extracellular T. gondii tachyzoites.
Validation of Protein Palmitoylation
To confirm that proteins identified in our proteomic analysis were
in fact palmitoylated, we carried out direct validation studies in
which specific proteins from our dataset were isolated by
immunoprecipitation and the presence of the palmitate analog
(17-ODYA) confirmed biochemically. MLC1 was previously sug-
gested to be palmitoylated (Fre´nal et al., 2010). Wemetabolically
labeled MLC1-FLAG-expressing parasites (Leung et al., 2014)(C) Table shows hypothetical proteins (Hypothetical), proteins with predicted trans
(Gly 2nd AA) expressed as a percentage of the total number of proteins from th
sensitive hits, membrane proteome, and the total predicted coding sequences in
(D) Venn diagram showing overlap between the entire P. falciparum palmitome an
Right circle (yellow) are the orthologs within theP. falciparum palmitome. Overlap (
of proteins identified.
(E) Venn diagram showing overlap between the 17-ODYA P. falciparum palmit
palmitome. Right circle (red) are the orthologs within the P. falciparum 17-ODYA p
are the number of proteins identified. See also Tables S1 and S2.
Cell Hostwith 17-ODYA, immunoprecipitated MLC1 with the FLAG
epitope, used Click chemistry to attach an azido-rhodamine flu-
orophore, and analyzed the labeled proteins by SDS-PAGE (Fig-
ure 3A). We observed a strong fluorescent signal associated with
MLC1, which was reduced by hydroxylamine treatment. These
results are consistent with the MS data and confirm that MLC1
is palmitoylated in tachyzoites.
We also identified the MLC1-binding partner MyoA as being
putatively palmitoylated in our dataset. Wemetabolically labeled
parasites expressing an N-terminal FLAG-tagged MyoA (Tang
et al., 2014) with 17-ODYA. Using the FLAG epitope, we immu-
noprecipitated MyoA and then labeled with azido-rhodamine.
We observed a fluorescent signal associated with MyoA by
SDS-PAGE that was lost by treatment with hydroxylamine (Fig-
ure 3B), indicating that MyoA is genuinely palmitoylated. In
addition to the rhodamine signal observed for MyoA, we de-
tected fluorescent signals from five other protein species that
co-precipitated with MyoA that were similarly hydroxylamine
sensitive (Figure 3B). Interestingly, the pattern of co-precipitatingmembrane domains (TM), and proteins with a glycine as the second amino acid
e following datasets: 17-ODYA enriched, highly hydroxylamine sensitive and
the genome (Total Predicted Proteome).
d the T. gondii palmitome. Left circle (blue) represents the T. gondii palmitome.
green) shows proteins identified in both datasets. Numbers indicate the number
ome and the T. gondii palmitome. Left circle (blue) represents the T. gondii
almitome. Overlap (purple) shows proteins identified in both datasets. Numbers
& Microbe 18, 501–511, October 14, 2015 ª2015 Elsevier Inc. 505
Figure 4. AMA1 Is Palmitoylated at
Cysteine 504
(A) Alignment of the transmembrane domain and
flanking residues of T. gondii AMA1 with the
corresponding region of AMA1 from several
Plasmodium species. Arrow indicates cysteine
504; line indicates predicted transmembrane
in T. gondii AMA1. Shading indicates conserva-
tion: black for good, gray for average, white
for non.
(B) Western blot for AMA1WT and four AMA1C504S
clones showing that AMA1C504S is expressed at
similar levels as AMA1WT. MLC1, loading control.
(C) Immunofluorescence microscopy of AMA1WT
and AMA1C504S intracellular parasites. AMA1-
FLAG staining is shown in green. GAP45 staining is
shown in red. Scale bar, 5 mm.
(D) Immunofluorescence microscopy of AMA1WT
and AMA1C504S extracellular parasites. AMA1-
FLAG staining is shown in green. GAP45 staining is
shown in red. Scale bar, 5 mm.
(E) AMA1-FLAG IP showing that Cys504 is
necessary for AMA1 palmitoylation. Top: rhoda-
mine fluorescent scan (R. scan) of SDS-PAGE
showing signal only in AMA1WT lane. Bottom:
corresponding western blot for AMA1 IP, probed
with anti-AMA1 antibody showing amount of
AMA1 immunoprecipitated (WB: AMA1). See also
Figure S3.proteins resembled the profile previously identified as the core
components of the glideosome (Fre´nal et al., 2010; Gaskins
et al., 2004). Given literature reports and the electrophoretic
mobility of the protein species, we tentatively annotated them
as GAP45 (a confirmed palmitoylated protein (Child et al.,
2013; Fre´nal et al., 2010), MLC1 (shown in this study to be palmi-
toylated), GAP40, and GAP50 (Figure 3B). However, without MS
identification of these MyoA-associated proteins we cannot
conclusively confirm their identity. GAP40 and GAP50 have not
previously been reported to be palmitoylated, but our proteomic
data indicated that they likely are, with GAP40 labeling being
highly hydroxylamine sensitive and GAP50 hydroxylamine sensi-
tive. We also observed a faint diffuse protein species between 50
and 70 kDa that was specific to the IP and also hydroxylamine
sensitive (Figure 3B). While the identity of this protein has yet
to be confirmed, based on a recent description of alternative
glideosome complexes, we believe that this protein is likely
either GAP70 or GAP80 (Fre´nal et al., 2014; Fre´nal et al., 2010).
Consistent with this assignment, GAP80 is present as a highly
hydroxylamine-sensitive hit in our dataset. Therefore, our data
suggest that the glideosome is a heavily palmitoylated complex
in tachyzoites.
Inhibition of palmitoylation has been shown to disrupt parasite
morphology (Alonso et al., 2012). Consistent with this, our chem-
ical proteomic approach identified PhIL1, which has been previ-
ously implicated in parasite morphology (Barkhuff et al., 2011),
as being palmitoylated. We metabolically labeled parasites ex-
pressing a GFP-tagged PhIL1 (Gilk et al., 2006) with 17-ODYA.
We immunoprecipitated PhIL1 and performed a click reaction506 Cell Host & Microbe 18, 501–511, October 14, 2015 ª2015 Elsevwith azido-rhodamine, observing a fluorescent signal that was
lost upon hydroxylamine treatment, confirming that PhIL1 is
also palmitoylated (Figure 3C).
AMA1 Is Palmitoylated
Identification of the invasion-associated protein AMA1 (Donahue
et al., 2000; Hehl et al., 2000; Lamarque et al., 2014; Mital et al.,
2005) as one of the highly hydroxylamine sensitive hits in our
dataset was intriguing, as palmitoylation has been implicated
in the regulation of host cell invasion (Alonso et al., 2012; Child
et al., 2013). We labeled parasites expressing FLAG-tagged
AMA1 (Parussini et al., 2012) with 17-ODYA, immunoprecipi-
tated AMA1 using the FLAG epitope, and labeled with azido-
rhodamine. We observed a strong fluorescent signal for AMA1
isolated from both extracellular (Figure 3D) and intracellular par-
asites (Figure S2), which was greatly reduced by hydroxylamine
treatment, indicating that AMA1 is palmitoylated.
We next sought to identify the site of palmitoylation on AMA1,
which contains 18 cysteine residues (Donahue et al., 2000; Hehl
et al., 2000). Structural studies indicate that 16 of these cysteines
form disulfide bridges in the protein’s extracellular domain and
are therefore not likely to be sites of palmitoylation (Crawford
et al., 2010). One of the remaining two cysteines lies within a pre-
dicted signal peptide, which is not expected to be part of the
mature protein (Donahue et al., 2000; Hehl et al., 2000). The re-
maining cysteine is located at position 504 in the C-terminal
end of the predicted TM domain, proximal to the cytosol-
exposed tail region (Figure 4A). This particular cysteine is not
conserved in P. falciparum and other related Plasmodium spe-
cies, although several Plasmodium species contain cysteinesier Inc.
Figure 5. Phenotypic Analysis of AMA1C504S
Strain
(A) Secretion of AMA1 and MIC2 is increased in
AMAC504S parasites. Anti-FLAG blot of the assay
supernatant shows the rate of constitutive AMA1
secretion, and the MIC2 blot shows the rate of
constitutive MIC2 secretion. GRA7 recovered in
the assay supernatant was used as a control.
(B) AMA1C504S parasites generate 40% fewer
plaques. Top, histogram of quantification of pla-
que assays for AMA1WT and AMA1C504S. Each bar
shows the mean of three biological replicates,
each performed in technical triplicate. Error bars
indicate SEM, calculated using two-tailed Stu-
dent’s t test (***p = 0.0009). Bottom, representative
images of plaque assays comparing AMA1WT and
AMA1C504S growth. Number of plaques is indi-
cated in the bottom right corner.
(C) AMA1C504S parasites invade host cells nor-
mally. Histogram presents quantification of three
independent invasion assays. Percent invasion
shown for AMA1C504S relative to AMA1WT invasion.
Error bars indicate SD; NS, not significant.
(D) AMA1C504S is defective at transitioning from
one parasite/vacuole to two parasites/vacuole
after being extracellular for 4 hr. Histogram pre-
sents quantification of three independent replica-
tion assays. Number of parasites/parasitophorous
vacuole is indicated. Significance was calculated
using Sidak’s multiple comparisons test (**p =
0.0092, *p = 0.019). Error bars denote SD. See also
Figure S4.at other positions within their TM domains (Figure 4A). PfAMA1,
which lacks this cysteine, was not identified in the P. falciparum
palmitome (Jones et al., 2012).
To determine if Cys504 was required for TgAMA1 palmitoyla-
tion, we generated parasite strains in which endogenous AMA1
was replaced with either wild-type (WT) FLAG-tagged allele
(AMA1WT) or a FLAG-tagged allele containing a Cys504Ser mu-
tation (AMA1C504S; Figure S3). AMA1C504S parasites were viable
and expressed AMA1C504S at steady-state levels equivalent to
those of AMA1WT (Figure 4B). The localization of AMA1C504S
was indistinguishable from AMA1WT in intracellular (Figure 4C)
and extracellular parasites (Figure 4D): staining was detectable
around the entire periphery of the parasite and concentrated at
the apical end, as previously described (Donahue et al., 2000;
Hehl et al., 2000). We metabolically labeled both AMA1WT and
the AMA1C504S strains with 17-ODYA, immunoprecipitated
AMA1 using the FLAG epitope, and labeled with azido-rhoda-
mine. AMA1WT yielded a strong fluorescent signal visualized by
SDS-PAGE, whereas the AMA1C504S showed no detectable
rhodamine fluorescence (Figure 4E). These data strongly sug-
gest that residue Cys504 is essential for, and likely the site of,
palmitoylation on AMA1.
Following secretion from the micronemes to the parasite
plasma membrane, AMA1 is cleaved within its TM domain by
the rhomboid protease ROM4 (Rugarabamu et al., 2015; Shen
et al., 2014), and its ectodomain is released from the parasite.
As Cys504 lies within the AMA1 TM domain, we hypothesized
that palmitoylation on this site might regulate AMA1 intramem-
brane cleavage and shedding. Microneme secretion assays,
which measure the combined effect of secretion to the parasiteCell Hostsurface and intramembrane proteolysis, revealed a striking in-
crease in the amount of AMA1C504S ectodomain released in the
culture supernatant compared to AMA1WT (Figures 5A and
S4C). Surprisingly, a similar increase was observed for the shed-
ding of the microneme protein 2 (MIC2) in the AMA1C504S
parasites (Figure 5D), suggesting that AMA1 palmitoylation influ-
ences the rate of microneme secretion. Secretion of a dense
granule marker (GRA7) and rhoptry marker (ROP1) was unaf-
fected (Figures 5A, S4C, and S4D), indicating that increased
secretion in the mutant is restricted to micronemes and is not
observed for other apical complex organelles.
In standard plaque assays, AMA1C504S parasites consistently
formed 40% fewer plaques than AMA1WT. However, the pla-
ques that formed were of roughly equal size (Figure 5B), and
the mutant parasites showed no detectable defect in invasion
(Figure 5C). Since the mutant parasites formed fewer plaques
but invaded normally, we tested whether the AMA1C504S plaqu-
ing defect resulted from an inability to complete the intracellular
phase of the lytic cycle. In initial replication assays with freshly
egressed parasites, we observed no difference in parasite intra-
cellular growth (data not shown). When the parasites were incu-
bated extracellularly for 4–5 hr before addition to host cells, there
was still no difference in the invasiveness of AMA1C504S and
AMA1WT parasites (Figure S4E). However, a smaller percentage
of the aged AMA1C504S parasites that invaded were able to com-
plete their intracellular replicative cycle compared to aged
AMA1WT parasites (Figure 5D), likely explaining the reduced
number of plaques observed in the mutants despite their
similar levels of invasion. Finally, recent studies have shown
that in the absence of AMA1, parasites upregulate AMA2 as a& Microbe 18, 501–511, October 14, 2015 ª2015 Elsevier Inc. 507
compensatory response (Lamarque et al., 2014). To investigate if
a similar compensation had occurred, we compared the expres-
sion levels of AMA2 and AMA4 by qPCR in the wild-type and
C504S mutant (Figures S4A and S4B). AMA4 expression levels
were unchanged; however, there was a slight, but significant,
downregulation of AMA2 in themutant. The underlying biological
significance and relationship to our phenotype remain to be
determined.
DISCUSSION
S-palmitoylation is the post-translational addition of a saturated
16-carbon fatty acid onto proteins via cysteine thiols (Tom and
Martin, 2013). Modern approaches enable proteome-wide iden-
tification of proteins modified by palmitate (Martin and Cravatt,
2009). These ‘‘palmitomes’’ have confirmed the presence of
this PTM through diverse aspects of biology and across
disparate branches of the tree of life. For example, a recent
study defined the palmitome of the apicomplexan parasite,
P. falciparum, concluding that palmitoylation plays a central
role in regulating blood-stage development (Jones et al., 2012).
Here, we applied a comprehensive DIA-MS chemoproteomic
approach to study palmitoylation of a related apicomplexan
parasite, T. gondii. Focusing on the asexual tachyzoite stage,
we discovered that palmitate is incorporated onto proteins
involved in all aspects of the tachyzoite lytic cycle, identifying
the majority of proteins previously predicted to be palmitoylated
in T. gondii (Table 1). Additionally, using a biochemical method
developed in our previous study (Child et al., 2013), we validated
our dataset and showed that multiple proteins not previously
known to be palmitoylated are modified by this PTM.
Despite growing knowledge of specific sites of palmitoylation,
recognition motifs that direct modification remain poorly defined
(Linder and Deschenes, 2007; Salaun et al., 2010). It is not clear if
the rules or motifs are evolutionarily conserved or if they are spe-
cific to a given organism of interest. CSS-Palm (http://csspalm.
biocuckoo.org/) is open-source software that provides a bio-
informatic prediction of the likelihood that a given cysteine will
be palmitoylated (Ren et al., 2008). CSS-Palm 4.0 predicts with
high confidence that approximately 56% percent (4,755/8,460)
of the coding genes in T. gondii produce potentially palmitoy-
lated proteins, compared with the 282 proteins identified in our
dataset (3.3% of the coding sequences in the genome). Consis-
tent with our data, CSS-Palm 4.0 predicts with high confidence
that AMA1 is palmitoylated. However, the software identifies a
cysteine within the predicted signal peptide of the molecule as
the likely site of modification, not Cys504, which we identified
as the likely site of palmitoylation. Our findings indicate that
caution should be exercised when using bioinformatic ap-
proaches to identify palmitoylated proteins.
In this study, we present the use of DIA-MS, an approach that
enables cross-experiment data extraction and quantitation for
improved label-free statistical analysis. While this approach pro-
vides robust statistical power for label-free analysis, the data are
likely inherently biased toward more abundant proteins or pro-
teins with higher modification stoichiometry. In addition, thresh-
olds applied to the hydroxylamine treatment dataset will group
proteins that are palmitoylated along with proteins modified by
multiple lipid acylations (e.g., palmitoylated and myristoylated).508 Cell Host & Microbe 18, 501–511, October 14, 2015 ª2015 ElsevGiven that T. gondii is often described as a model organism
for P. falciparum (Kim and Weiss, 2004), the limited overlap
between the published palmitome for this related parasite
and our dataset is surprising. This lack of overlap may be
due to low homology between the species and subsequent
difficulty in identifying orthologs in silico. However, the biology
of these two organisms differs in many respects, and the
lack of overlap may indicate that most palmitoylation is para-
site specific. A good example of this is demonstrated
here; TgAMA1 is palmitoylated, while PfAMA1 is not (Jones
et al., 2012). Conversely, proteins that do overlap between
datasets could represent evolutionarily conserved palmitoyla-
tion events.
Highlighting the critical role palmitoylation likely plays in the
formation and/or function of the glideosome complex, we iden-
tified most components of the MyoA glideosome (MyoA,
MLC1, GAP45, GAP40, and GAP50) within the MS dataset as
palmitoylated protein species (Table S1). Moreover, a recent
study investigating functional plasticity of glideosome compo-
nents described an alternative, basally localized glideosome
complex referred to as the MyoC glideosome (Fre´nal et al.,
2014). Consistent with the underlying functional significance of
palmitoylation for the glideosome, our proteomic study identified
GAP80 and IAP1, two components of the MyoC glideosome
(Fre´nal et al., 2014) as highly hydroxylamine-sensitive hits.
Notably, MyoC was absent from our data.
We have shown that AMA1 in T. gondii has a previously un-
identified palmitoylation site. Although AMA1 has been impli-
cated in attachment and/or invasion (Bargieri et al., 2013,
2014; Hehl et al., 2000; Lamarque et al., 2014; Mital et al.,
2005; Tyler et al., 2011), parasites expressing the AMA1 palmi-
toylation site mutant invade normally. One phenotype associ-
ated with mutation of the AMA1 palmitolyation site is a marked
increase in the secretion of AMA1 and other microneme proteins,
suggesting a previously unrecognized role for AMA1 in regu-
lating microneme secretion. We also observed that mutant par-
asites that remain extracellular for 4 hr prior to invasion are less
likely to complete their lytic cycle. The biological relevance of this
observation is unclear. It may reflect involvement of TgAMA1 in
intracellular replication, which would be consistent with the
previous suggestion that intramembrane cleavage of TgAMA1
triggers parasite replication (Santos et al., 2011). However, other
work has shown that parasites expressing non-cleavable mu-
tants of TgAMA1 (Parussini et al., 2012) or lacking AMA1 alto-
gether (Bargieri et al., 2013) replicate indistinguishably from
wild-type, as do parasites lacking the rhomboid proteases
necessary for TgAMA1 intramembrane cleavage (Rugarabamu
et al., 2015; Shen et al., 2014), casting doubt on the connection
between TgAMA1 cleavage and replication initiation. Palmitoyla-
tion of AMA1 could instead be involved in some previously
unidentified function of the protein, such as fission of the parasi-
tophorous vacuole membrane from the host cell plasma mem-
brane during the final stages of invasion, although this would
not explain why the phenotype only manifests after the parasites
have been extracellular for 4 hr. It could be that enhanced secre-
tion of microneme proteins in AMA1C504S parasites while extra-
cellular exhausts them of a protein normally secreted from the
micronemes intracellularly, which is needed to complete the lytic
cycle. Further studies will be required to test the hypothesis thatier Inc.
microneme secretion occurs intracellularly and plays a role in the
parasite’s lytic cycle. Finally, it is formally possible that pheno-
types observed are not a direct consequence of the mutation
introduced into AMA1, but rather a compensatory change
induced by the mutation (Fre´nal and Soldati-Favre, 2015) such
as downregulated expression of AMA2 (Figure S4A).
Recent studies dissecting the function of AMA1 cleavage from
the surface of the parasite by the rhomboid proteases ROM4 and
ROM5 have determined that the bulk of AMA1 is cleaved by
ROM4, with a small proportion cleaved by ROM5 (Rugarabamu
et al., 2015; Shen et al., 2014). Our data indicate that ROM4 is
palmitoylated, and so palmitoylation could be a mechanism to
organize enzyme and substrate. Furthermore, Rugarabamu
and colleagues suggest that ‘‘The restricted access of ROM5
to a large pool of AMA1 is plausibly due to distinct lipid microen-
vironment or more likely as a result of compartmentalization,’’
(Rugarabamu et al., 2015). It is intriguing to speculate that
when AMA1 is not palmitoylated a greater proportion of the
pool can be accessed by ROM5 and that the shift in the pools
of the AMA1 accessed by ROM4 and ROM5 functionally contrib-
utes to the phenotypes observed herein.
In conclusion, we have generated a dataset that implicates
palmitoylation in distinct aspects of Toxoplasma biology and
have validated the palmitoylation of several proteins. In the
case of extensively studied TgAMA1, we have shown that mu-
tation of the likely palmitoylation site has no effect on invasion
but causes a marked increase in microneme secretion, sug-
gesting a role for AMA1 in this process. We have shown that
this dataset can unlock unexpected biology for even the most
well-studied proteins and will be a powerful resource for the
future.
EXPERIMENTAL PROCEDURES
Labeling with 17-ODYA and Palmitic Acid
Parasites were labeled overnight (16 hr) in culture medium with 25 mM pal-
mitic acid or 25 mM 17-ODYA. Parasites were isolated by syringe lysis from
HFFs, spun at 1200 3 g for 5 min to remove host cell debris. Intracellular par-
asites were labeled as described, with infected host cells scraped, spun down,
and washed in PBS to collect intracellular parasites.
Validation of Palmitoylation
Labeled parasites were lysed by sonication in 13 PBS with 10 mM PMSF and
20 mM HDSF. Membranes were pelleted by centrifugation at 100,000 3 g for
1 hr at 4C. Protein concentration was assessed by BCA. GFP IP setup was
as follows: 60 ml of GFP-TRAP A beads from Chromotek were incubated
with 200 mg of membrane lysate and IP buffer (150 mM NaCl, 20 mM HEPES
[pH 7.4], 0.1% SDS, 0.5% NP40) for a total volume of 200 ml. IPs were incu-
bated overnight at 4C, then washed 33 with cold IP buffer, 23 with cold
wash buffer (150 mM NaCl, 20 mM HEPES [pH 7.4]), and once with cold 13
PBS. Beads were resuspended in a 50 ml click reaction (1 mM CuSO4, 1 mM
TCEP, 100 mM Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine [ligand], and
20 mM Azido-Rhodamine in 13 PBS). Reactions were incubated for 1 hr at
23C, then split in half. NH2OH (5% of total) was added to half of the reaction
and incubated for 30 min at 23C. Protein was eluted from beads by boiling in
sample buffer and separated by SDS-PAGE. FLAG IPs were performed as for
GFP, using 60 ml Sigma anti-FLAG M2 affinity gel. Gels were scanned on an
Amersham Bioscience Typhoon 9410 variable mode imager using the
580 bp Filter with the green 532 laser. Gels were transferred to nitrocellulose
and westerns performed to confirm IP of protein of interest. Western blots
for AMA1 were performed using UVT-59 (Donahue et al., 2000), for TgMLC1
using anti-TgMLC1, for FLAG using anti-FLAG M2 (Sigma), and for GFP using
the GF28R (Thermo Scientific) antibody.Cell HostFor inputs, 50 mg of membrane lysate were added to a 50 ml click reaction
described above. Reactions were incubated for 1 hr at 23C and boiled in
sample buffer. 5 mg were loaded for each input.
Invasion and Plaque Assays
Laser scanning cytometer-based invasion assays were done as previously
described (Mital et al., 2005), with the following modifications: (a) the parasites
were allowed to settle onto the HFF monolayers for 20 min at 23C before in-
cubation at 37C for 1 hr; and anti-SAG1 primary, RPE-conjugated secondary,
and Alexa 647-conjugated secondary antibodies were used at dilutions of
1:250, 1:400, and 1:200, respectively. A total of three biological replicates
(each done in duplicate) were performed; Student’s t test was applied to the
means of the biological replicates.
Plaque assays were set up immediately following the initiation of invasion
assays, using the same parasite suspensions. Fifty parasites were added to
each well of a 12-well plate containing confluent host cell HFF monolayers.
The plate was incubated for 7 days in the 37C incubator with 5%CO2 and hu-
midity, then stained with 2% crystal violet and 20%methanol in PBS for 5 min
at 23C. The stained wells were washedwith water, and the number of plaques
per well were counted.
Replication Assay
WT and C504S parasites were harvested and allowed to sit at 23C for 4 hr in
DMEM with 1% FBS. Parasites were counted, and 5 3 105 parasites were
added to 25 mm coverslips with confluent human foreskin fibroblasts. After
14 hr, coverslips were fixed on ice with 100% cold methanol for 5 min. Indirect
IFAs were performed using anti-GRA8 and anti-GAP45 antibodies as previ-
ously described (Carey et al., 2000). A total of three biological replicates
were performed with triplicates in each, and 250 vacuoles were counted per
coverslip. Two-way ANOVA with Sidak’s multiple comparisons test was
performed.
Additional details can be found in the Supplemental Information.
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